[1]杨春霞.D-二聚体检测及临床应用研究[J].医学信息,2023,36(12):189-192.[doi:10.3969/j.issn.1006-1959.2023.12.040]
　YANG Chun-xia.Research on D-dimer Detection and Clinical Application[J].Journal of Medical Information,2023,36(12):189-192.[doi:10.3969/j.issn.1006-1959.2023.12.040]
点击复制

D-二聚体检测及临床应用研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年12期
页码:
189-192
栏目:
综述
出版日期:
2023-06-15

文章信息/Info

Title:
Research on D-dimer Detection and Clinical Application
文章编号:
1006-1959（2023）12-0189-04
作者:
杨春霞
（天津市蓟州区人民医院检验科，天津 301999）
Author(s):
YANG Chun-xia
(Laboratory Department of Jizhou People’s Hospital,Tianjin 301999,China)
关键词:
D-二聚体; 纤维蛋白; 血栓; 急性冠脉综合征
Keywords:
D-dimer; Fibrin; Thrombosis; Acute coronary syndrome
分类号:
R446
DOI:
10.3969/j.issn.1006-1959.2023.12.040
文献标志码:
A
摘要:
D-二聚体是可溶的纤维蛋白降解产物，是由纤维蛋白溶解系统对血栓的有序分解产物，是临床凝血和纤溶激活的重要检测指标。因D-二聚体检测具有高度敏感性和阴性预测能力，使其在临床静脉血栓形成、弥漫性血管内凝血、急性冠脉综合征等疾病的鉴别诊断和治疗监测方面得到广泛应用。但D-二聚体检测多样化，不同检测方法检测结果存在差异；且D-二聚体表达水平受个体差异影响，一定程度限制了D-二聚体在临床的应用。本文主要就D-二聚体的形成机制、检测方法以及在临床的应用进行综述，以期为D-二聚体检测的合理应用提供参考依据。
Abstract:
D-dimer is a soluble fibrin degradation product, which is an orderly decomposition product of thrombus by fibrinolysis system. It is an important detection index of clinical coagulation and fibrinolysis activation. Because of its high sensitivity and negative predictive ability, D-dimer detection has been widely used in the differential diagnosis and treatment monitoring of clinical venous thrombosis, diffuse intravascular coagulation, acute coronary syndrome and other diseases. However, the detection of D-dimer is diversified, and the results of different detection methods are different. The expression level of D-dimer is affected by individual differences, which limits the clinical application of D-dimer to a certain extent. This article mainly reviews the formation mechanism, detection methods and clinical application of D-dimer, in order to provide reference for the rational application of D-dimer detection.

参考文献/References:

[1]Weitz JI,Fredenburgh JC,Eikelboom JW.A Test in Context: D-Dimer[J].J Am Coll Cardiol,2017,70(19):2411-2420.[2]田文芳,易素芬,郑水华.纤溶酶－α2纤溶酶抑制物复合物凝血酶抗凝血酶复合物血栓调节蛋白测定弥散性血管内凝血早期诊断中的意义[J].实用医技杂志,2019,26(1):7-9.[3]Takeshima M,Ishikawa H,Shimizu K,et al.Incidence of venous thromboembolism in psychiatric inpatients:a chart review[J].Neu ropsychiatr Dis Treat,2018,14:1363-1370.[4]Linkins LA,Takach Lapner S.Review of D-dimer testing: Good, bad,and ugly[J].Int J Lab Hematol,2017,39(Suppl 1):98-103.[5]张玥,亓雪,刘湘,等.血小板参数、纤维蛋白原和D-二聚体对深静脉血栓形成中不同中医证型的诊断价值[J].国际中医中药杂志,2021,43(8):751-756.[6]张鸿艳,任静,杨晴,等.D-二聚体2种检测方法的参考值建立和排除静脉血栓栓塞症临界值设定[J].临床检验杂志,2020,28(6):175-177.[7]侯寒进,蒋佳利,冯文卓,等.光激化学发光法在D-二聚体单克隆抗体筛选中的应用[J].吉林医药学院学报,2020,11(9):79-81.[8]杨宏伟,樊一笋.免疫比浊法测定D-二聚体假阳性病例干扰分析[J].临床检验杂志,2022,40(5):361-363.[9]王晓丽,李林.D-二聚体胶体金免疫层析法定量检测试剂盒性能评价[J].生物化工,2021,25(6):171-173.[10]王孝高,王颖,宋涛,等.D-二聚体在下肢深静脉血栓形成导管溶栓过程中疗效评估的作用[J].重庆医学,2020,19(3):327-329.[11]马明静,刘道阔,王庆凯,等.D-二聚体水平在下肢深静脉血栓形成治疗中的监测价值研究[J].中国循证心血管医学杂志,2017,20(1):491-493.[12]袁武锋,蒋雷,郑素洁.尿激酶溶栓治疗对下肢深静脉血栓合并急性肺栓塞患者凝血功能、D-二聚体、N-末端脑钠肽前体的影响[J].中华全科医学,2017,12(8):242-245.[13]沈烨琪,徐良额,张圣,等.血清D-二聚体在急性缺血性脑卒中静脉溶栓出血转化及预后预测中的价值研究[J].浙江医学,2020,30(5):179-181.[14]蒋陈晓,杨婷,郗有丽,等.D-二聚体水平对急性脑梗死患者溶栓疗效的预测意义[J].内科急危重症杂志,2020,15(2):140-143.[15]连丽霞,张佩兰,罗玉福,等.比较静脉溶栓与双抗治疗脑梗死后PLT、凝血指标、D-二聚体变化[J].中风与神经疾病杂志,2017,30(1):202-205.[16]黄晶,刘颖,吴正刚,等.血清D-二聚体与急性缺血性脑卒中患者rt-PA静脉溶栓后早期神经功能改善及预后的关系[J].中国实用神经疾病杂志,2019,10(5):162-164.[17]杜秀娟,曾覃平,张秀梅,等.血栓弹力图、纤维蛋白原及D-二聚体检测在恶性肿瘤患者凝血功能评估中的应用[J].检验医学与临床,2019,27(8):400-403.[18]王猛,于丹军,刘匀,等.血浆凝血与纤溶标志物对急性白血病合并DIC患者早期诊断及预后的评估价值[J].贵州医科大学学报,2020,45(8):938-942.[19]Aisabokhale FA,Akingbola TS,Bamidele K.D-dimer as a Predic- tor of Altered Coagulation in HIV Patients in Nigeria[J].Niger J Physiol Sci,2019,34(1):99-105.[20]杨帆,高盼.血小板参数、D-二聚体在妊娠高血压综合征早期肾损伤患者中的表达及临床意义[J].陕西医学杂志,2021,5(4):55-58.[21]陈磊.联合检测FDP和D-D对妊娠高血压综合征诊断的临床意义[J].吉林医学,2018,15(2):63-65.[22]樊和斌,陈彩云,杨东亮,等.D-二聚体在肝硬化、肝癌患者中的临床价值[J].胃肠病学和肝病学杂志,2017,20(8):111-114.[23]袁成立.纤维蛋白原、活化部分凝血活酶时间、凝血酶原时间、凝血酶时间、D-二聚体检测对评定肝硬化患者肝损伤程度的意义[J].吉林医学,2018,15(5):349-352.[24]张宁,何小帆,张亚亚.凝血四项联合D-二聚体(D-D)水平检测在乙型肝炎肝硬化患者出血风险预测中的应用价值分析[J].四川解剖学杂志,2020,12(2):91-94.[25]卢建新,陈晓敏,陈作波.晚期肝癌患者血浆纤维蛋白原和D-二聚体水平变化的影响[J].实用癌症杂志,2018,14(6):60-64.[26]徐静,纪冬,王春艳,等.乙型肝炎肝硬化患者血浆D-二聚体水平变化的临床意义[J].临床肝胆病杂志,2020,15(3):192-194.[27]黄爱红,张庆仪,何智.2型糖尿病肾病患者血清D-二聚体和胆红素水平变化及意义[J].国际检验医学杂志,2018,14(12):127-129.[28]陶莉莉.D-D/ADDD临界值联合ADDRS在诊断急性主动脉夹层中的应用[D].昆明:昆明医科大学,2020.[29]张玲玲.D-二聚体在急性主动脉夹层预后及临床分型的价值[D].石家庄:河北医科大学,2021.

相似文献/References:

[1]和珍珍,吴彦洪,刘艳,等.凝血指标测定对诊断胎盘早剥的价值分析[J].医学信息,2018,31(01):153.[doi:10.3969/j.issn.1006-1959.2018.01.060]
　HE Zhen-zhen,WU Yan-hong,LIU Yan,et al.Value Analysis of Coagulation Index in Diagnosing Placental Abruption[J].Journal of Medical Information,2018,31(12):153.[doi:10.3969/j.issn.1006-1959.2018.01.060]
[2]孙朝霞,曹显刚,赵 利,等.发热伴血小板减少综合征患者D-二聚体、心肌酶谱及肝酶谱的检测[J].医学信息,2018,31(03):85.[doi:10.3969/j.issn.1006-1959.2018.03.026]
　SUN Zhao-xia,CAO Xian-gang,ZHAO li,et al.Detection of D-Dimer,Myocardial and Liver Enzymes in Patients with Fever and Thrombocytopenia Syndrome[J].Journal of Medical Information,2018,31(12):85.[doi:10.3969/j.issn.1006-1959.2018.03.026]
[3]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
　FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Journal of Medical Information,2018,31(12):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[4]赵华莹,李运泽,韦天灵,等.肝硬化合并门静脉血栓形成的危险因素分析[J].医学信息,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
　ZHAO Hua-ying,LI Yun-ze,WEI Tian-ling,et al.Analysis of Risk Factors for Cirrhotic Patients with Portal Vein Thrombosis[J].Journal of Medical Information,2019,32(12):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
[5]宫园园.LDL、Hcy、D-二聚体及颈动脉粥样硬化与急性缺血性脑卒中相关性研究[J].医学信息,2019,32(05):117.[doi:10.3969/j.issn.1006-1959.2019.05.036]
　GONG Yuan-yuan.Correlation between LDL,Hcy,D-dimer and Carotid Atherosclerosis and Acute Ischemic Stroke[J].Journal of Medical Information,2019,32(12):117.[doi:10.3969/j.issn.1006-1959.2019.05.036]
[6]祁 闻,赵 红,王龙胜,等.肺栓塞CTPA间接征象诊断价值分析及临床意义[J].医学信息,2019,32(08):88.[doi:10.3969/j.issn.1006-1959.2019.08.026]
　QI Wen,ZHAO Hong,WANG Long-sheng,et al.Diagnostic Value and Clinical Significance of CTPA indirect signs in Pulmonary Embolism[J].Journal of Medical Information,2019,32(12):88.[doi:10.3969/j.issn.1006-1959.2019.08.026]
[7]杜治国,何 龙,黄 进,等.下肢创伤骨折后静脉血栓栓塞症相关检测项目分析[J].医学信息,2019,32(10):64.[doi:10.3969/j.issn.1006-1959.2019.10.022]
　DU Zhi-guo,HE Long,HUANG Jin,et al.Analysis of Related Items of Venous Thromboembolism after Traumatic Fracture of Lower Extremity[J].Journal of Medical Information,2019,32(12):64.[doi:10.3969/j.issn.1006-1959.2019.10.022]
[8]李大千,蒋 云,梅燕萍.抗凝血酶Ⅲ、D-二聚体与纤维蛋白原在 下肢静脉血栓形成中的临床应用[J].医学信息,2019,32(17):167.[doi:10.3969/j.issn.1006-1959.2019.17.057]
　LI Da-qian,JIANG Yun,MEI Yan-ping.Clinical Application of Antithrombin III,D-dimer and Fibrinogen in Venous Thrombosis of Lower Extremity[J].Journal of Medical Information,2019,32(12):167.[doi:10.3969/j.issn.1006-1959.2019.17.057]
[9]龚嘉玮,朱旭日,徐 锋,等.化瘀定痛液联合低分子肝素治疗老年粗隆间骨折围手术期肿痛的效果[J].医学信息,2020,33(03):148.[doi:10.3969/j.issn.1006-1959.2020.03.048]
　GONG Jia-wei,ZHU Xu-ri,XU Feng,et al.Effect of Huayudingtong Liquid Combined with Low-molecular-weight Heparin on Perioperative Swelling and Pain in Elderly Intertrochanteric Fractures[J].Journal of Medical Information,2020,33(12):148.[doi:10.3969/j.issn.1006-1959.2020.03.048]
[10]阙禄辉.闭合性骨折后下肢DVT患者D-二聚体、纤维蛋白原与Caprini评分的相关性分析[J].医学信息,2020,33(04):101.[doi:10.3969/j.issn.1006-1959.2020.04.030]
　QUE Lu-hui.Correlation Analysis of D-Dimer,Fibrinogen and Caprini Score in Patients with Lower Extremity DVT After Closed Fracture[J].Journal of Medical Information,2020,33(12):101.[doi:10.3969/j.issn.1006-1959.2020.04.030]

更新日期/Last Update: 1900-01-01